Merck Basic EPS 2010-2024 | MKKGY
Merck annual/quarterly basic eps history and growth rate from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- Merck basic eps for the quarter ending June 30, 2024 was $1.51, a 14.61% decline year-over-year.
- Merck basic eps for the twelve months ending June 30, 2024 was $6.54, a 11.71% decline year-over-year.
- Merck annual basic eps for 2023 was $0.007B, a 12.85% decline from 2022.
- Merck annual basic eps for 2022 was $0.008B, a 3.09% decline from 2021.
- Merck annual basic eps for 2021 was $0.008B, a 59.33% increase from 2020.
| Merck Annual Basic EPS |
| 2023 |
$7.02 |
| 2022 |
$8.06 |
| 2021 |
$8.32 |
| 2020 |
$5.22 |
| 2019 |
$3.41 |
| 2018 |
$9.17 |
| 2017 |
$6.76 |
| 2016 |
$4.15 |
| 2015 |
$2.84 |
| 2014 |
$2.98 |
| 2013 |
$3.68 |
| 2012 |
$1.68 |
| 2011 |
$1.87 |
| 2010 |
$1.93 |
| 2009 |
$1.18 |
| Merck Quarterly Basic EPS |
| 2024-06-30 |
$1.51 |
| 2024-03-31 |
$1.74 |
| 2023-12-31 |
$1.44 |
| 2023-09-30 |
$1.85 |
| 2023-06-30 |
$1.77 |
| 2023-03-31 |
$1.96 |
| 2022-12-31 |
$1.54 |
| 2022-09-30 |
$2.14 |
| 2022-06-30 |
$2.12 |
| 2022-03-31 |
$2.27 |
| 2021-12-31 |
$2.12 |
| 2021-09-30 |
$2.06 |
| 2021-06-30 |
$2.06 |
| 2021-03-31 |
$2.07 |
| 2020-12-31 |
$1.16 |
| 2020-09-30 |
$2.16 |
| 2020-06-30 |
$0.74 |
| 2020-03-31 |
$1.16 |
| 2019-12-31 |
$0.82 |
| 2019-09-30 |
$0.88 |
| 2019-06-30 |
$1.21 |
| 2019-03-31 |
$0.49 |
| 2018-12-31 |
$6.62 |
| 2018-09-30 |
$0.91 |
| 2018-06-30 |
$0.68 |
| 2018-03-31 |
$0.96 |
| 2017-12-31 |
$2.68 |
| 2017-09-30 |
$1.74 |
| 2017-06-30 |
$1.07 |
| 2017-03-31 |
$1.28 |
| 2016-12-31 |
$0.67 |
| 2016-09-30 |
$1.17 |
| 2016-06-30 |
$0.81 |
| 2016-03-31 |
$1.50 |
| 2015-12-31 |
$0.32 |
| 2015-09-30 |
$0.94 |
| 2015-06-30 |
$0.87 |
| 2015-03-31 |
$0.74 |
| 2014-12-31 |
$0.72 |
| 2014-09-30 |
$0.76 |
| 2014-06-30 |
$0.94 |
| 2014-03-31 |
$2.06 |
| 2013-12-31 |
$0.88 |
| 2013-09-30 |
$1.04 |
| 2013-06-30 |
$0.96 |
| 2013-03-31 |
$0.79 |
| 2012-12-31 |
$0.81 |
| 2012-09-30 |
$0.53 |
| 2012-06-30 |
$-0.18 |
| 2012-03-31 |
$0.51 |
| 2011-12-31 |
$0.41 |
| 2011-09-30 |
$0.74 |
| 2011-06-30 |
$-0.29 |
| 2011-03-31 |
$1.08 |
| 2010-12-31 |
$0.21 |
| 2010-09-30 |
$0.63 |
| 2010-06-30 |
$0.51 |
| 2010-03-31 |
$0.59 |
| 2009-12-31 |
$0.51 |
| 2009-09-30 |
$0.16 |
| 2009-06-30 |
$0.34 |
| 2009-03-31 |
$0.17 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
